Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics and services some of the most prestigious medical institutions in the world. Our tests target cancers that are difficult to diagnose and predict treatment outcomes. These cancers include hematological, urogenital and HPV-associated cancers. We also offer a comprehensive range of non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. We have established strong research collaborations with major cancer centers such as Memorial Sloan-Kettering, The Cleveland Clinic, Mayo Clinic and the National Cancer Institute. For further information, please see www.cancergenetics.com.
Latest Results: Q4 2014 Quarterly
International Society for Biological and Environmental Repositories
May 5 2015 - May 9 2015 • Phoenix, AZ
- Apr 16 2015 7:45 AM EDT Cancer Genetics, Inc. Receives New York State Licensure for FHACT(R) Cervical Cancer Test
- Apr 1 2015 8:25 AM EDT Cancer Genetics, Inc. Increases Access to Its Comprehensive Cancer Diagnostic Tests & Services Through Agreement With America's Choice Provider Network(R)
- Mar 23 2015 7:30 AM EDT Cancer Genetics, Inc. to Present Results From Three Major Clinical Research Collaborations at USCAP Showcasing the Importance of Genomic Panels for Cancer Identification and Management
Cancer Genetics, Inc.
201 Route 17 North
Rutherford, NJ 07070
Life Science Advisors LLC